$HIPH SeeThruEquity analysts have placed a price t

$ HIPH SeeThruEquity analysts have placed a price target on HIPH common shares at $0.30 , which represents a potential upside of 471.4% from the recent price of $0.0525 on Oct. 9, 2018. In the report, the firm further outlines expectations for the Company, as the launch of its CBD beverage enables HIPH to enter the large and rapidly growing CBD market, which, in the U.S., generated sales of $820 million in 2017 and is projected to grow at a compounded rate of 54% to reach $3 billion by 2020, according to Greenware Advisors. The firm also highlights potential growth on the pharma side, as HIPH is optimistic it will benefit from the recent DEA action removing CBD as Schedule 1 drug when there is 0.1% or less trace amounts of THC. Such products will now be classified as Schedule 5 drugs, as long as the medications have been approved by the FDA. While LALPINA Hydro CBD is not FDA-approved, it contains non-detectable amounts of THC, and HIPH may now be in a position to explore partnerships for medical applications of a formulation of its product. The full report can be viewed at http://www.seethruequity.com.

What I post is my opinion. Do your own DD. Make your own investment decision. Links, images, & retweets are not endorsements.

1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.